Morgan Stanley lowered its price target on Gilead Sciences (NASDAQ: GILD) to $81.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Gilead Sciences (GILD) PT Lowered to $90 at RBC CapitalMay 2, 2018 8:26 AM Gilead Sciences (GILD) PT Lowered to $79 at BairdMay 2, 2018 7:51 AM Gilead Sciences (GILD) PT Lowered to $89 at Maxim GroupMay 2, 2018 7:42 AM Too many cancer drugs? Crowded market gives investors pauseMay 2, 2018 7:14 AM Gilead Sciences (GILD) PT Lowered to $85 at CowenMay 2, 2018 6:31 AM Gilead Sciences (GILD) PT Lowered to $72 at Leerink PartnersMay 2, 2018 6:23 AM Gilead (GILD) volatility elevated into less than expected Q1 results May 2, 2018 3:54 AM Gilead Sciences (GILD) PT Lowered to $90 at BarclaysMay 2, 2018 3:54 AM Options expected to have increasing volume: AAPL JNPR SNAP YUMC GILDMay 2, 2018 2:48 AM After-Hours Stock Movers 05/01: (CRAY) (CYH) (AAPL) Higher; (SNAP) (YUMC) (GILD) Lower (more...)May 1, 2018 6:33 PM Gilead Sciences (GILD) Declares $0.57 Quarterly Dividend; 3.2% YieldMay 1, 2018 4:02 PM Gilead Sciences (GILD) Misses Q1 EPS by 19c, Reiterates FY GuidanceMay 1, 2018 4:02 PM Gilead Sciences Announces Second Quarter 2018 DividendMay 1, 2018 4:02 PM Gilead Sciences Announces First Quarter 2018 Financial ResultsMay 1, 2018 4:01 PM Gilead Sciences (GILD) call put ratio 2.1 calls to 1 put with focus on May weekly 73.50 & May 72.50 calls May 1, 2018 10:31 AM Model N Launches Digital Reinvention LabMay 1, 2018 9:00 AM Gilead Sciences (GILD) May weekly option implied volatility bid into Q1 and outlookMay 1, 2018 5:41 AM Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of Inflammatory DiseasesApril 30, 2018 4:05 PM Gilead Sciences (GILD) May weekly option implied volatility bid into Q1 and outlookApril 30, 2018 2:01 PM